USD 11.73
(-4.71%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 14.36 Billion USD | -7.29% |
2022 | 15.49 Billion USD | -6.02% |
2021 | 16.48 Billion USD | -6.84% |
2020 | 17.69 Billion USD | 96.9% |
2019 | 8.98 Billion USD | 0.32% |
2018 | 8.95 Billion USD | 0.18% |
2017 | 8.94 Billion USD | 10.38% |
2016 | 8.09 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 14.01 Billion USD | -2.39% |
2024 Q2 | 13.76 Billion USD | -1.82% |
2023 FY | 14.36 Billion USD | -7.29% |
2023 Q1 | 15.76 Billion USD | 1.79% |
2023 Q2 | 15.79 Billion USD | 0.17% |
2023 Q3 | 14.34 Billion USD | -9.19% |
2023 Q4 | 14.36 Billion USD | 0.13% |
2022 Q2 | 15.6 Billion USD | -4.0% |
2022 FY | 15.49 Billion USD | -6.02% |
2022 Q4 | 15.49 Billion USD | 3.63% |
2022 Q3 | 14.94 Billion USD | -4.19% |
2022 Q1 | 16.25 Billion USD | -1.41% |
2021 Q2 | 16.83 Billion USD | -0.91% |
2021 Q3 | 16.56 Billion USD | -1.59% |
2021 FY | 16.48 Billion USD | -6.84% |
2021 Q4 | 16.48 Billion USD | -0.5% |
2021 Q1 | 16.98 Billion USD | -3.98% |
2020 Q1 | 9.72 Billion USD | 8.25% |
2020 Q2 | 9.87 Billion USD | 1.53% |
2020 Q3 | 17.23 Billion USD | 74.53% |
2020 FY | 17.69 Billion USD | 96.9% |
2020 Q4 | 17.69 Billion USD | 2.64% |
2019 Q4 | 8.98 Billion USD | 1.84% |
2019 Q1 | 8.74 Billion USD | -2.34% |
2019 Q3 | 8.82 Billion USD | -0.37% |
2019 FY | 8.98 Billion USD | 0.32% |
2019 Q2 | 8.85 Billion USD | 1.25% |
2018 Q1 | - USD | -100.0% |
2018 FY | 8.95 Billion USD | 0.18% |
2018 Q4 | 8.95 Billion USD | -2.77% |
2018 Q3 | 9.21 Billion USD | 7.39% |
2018 Q2 | 8.57 Billion USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | 8.94 Billion USD | 0.0% |
2017 FY | 8.94 Billion USD | 10.38% |
2016 FY | 8.09 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Amneal Pharmaceuticals, Inc. | 3.47 Billion USD | -313.584% |
Bausch Health Companies Inc. | 27.35 Billion USD | 47.488% |
Catalent, Inc. | 9.75 Billion USD | -47.257% |
Emergent BioSolutions Inc. | 1.83 Billion USD | -682.713% |
Perrigo Company plc | 10.8 Billion USD | -32.87% |
Teva Pharmaceutical Industries Limited | 43.47 Billion USD | 66.968% |
Zoetis Inc. | 14.28 Billion USD | -0.532% |